A Review of Empirical Evidence of Somatic Treatment Options for the MI/DD Population

@article{Ulzen2008ARO,
  title={A Review of Empirical Evidence of Somatic Treatment Options for the MI/DD Population},
  author={T. Ulzen and R. Powers},
  journal={Psychiatric Quarterly},
  year={2008},
  volume={79},
  pages={265-273}
}
This article reviews recent evidence in the literature for the use of psychotropic and other somatic treatments in the management of patients with mental retardation (MR). The search methodology included peer-reviewed English language publications in PubMed and PsychINFO with the words Mental Retardation, Intellectual Disability, Developmental Disability and Mental Disorders/Drug Therapy or Antipsychotic medications, Psychiatric Somatic therapies, Neuroleptic Drugs, Antidepressants and… Expand
Psychiatric Services for Individuals with Intellectual and Developmental Disabilities: Medication Management
TLDR
The study found that psychiatric care in the clinic led to a simplification of medication regimens, and for individuals taking prescribed psychiatric medications at referral, psychiatric medication polypharmacy and same-class psychiatric medication polygarmacy were reduced by discharge. Expand
Effectiveness of interventions for adults with mild to moderate intellectual disabilities and mental health problems: systematic review and meta-analysis
TLDR
There is no compelling evidence supporting interventions aiming at improving mental health problems in people with mild to moderate intellectual disability, and some interventions are promising and should be evaluated further in larger and more rigorous trials. Expand
Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
TLDR
The structured medication review is a valuable instrument to optimize pharmacotherapy and to support psychiatrists in adequate prescribing of both psychotropic and somatic drugs. Expand
Neurodevelopmental and psychiatric issues in Down’s syndrome: assessment and intervention
TLDR
An overview is presented of state-of-the-art knowledge of the neurocognitive, neurobiological and psychopathological profile, assessment and treatment of patients with Down’s syndrome and the only effective approach for improving cognitive and linguistic abilities is rehabilitation. Expand
The neurobiology of aggression: implications for the pharmacotherapy of aggressive challenging behaviour by people with intellectual disabilities.
  • P. Willner
  • Psychology, Medicine
  • Journal of intellectual disability research : JIDR
  • 2015
TLDR
With the possible exception of risperidone, there is no reliable evidence that antidepressant, neuroleptic or anticonvulsant drugs are effective treatments for aggression by people with ID. Expand
Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland
TLDR
This study showed that polypharmacy and inappropriate prescription are very common in adults with ID, even though the literature and expert positions advocate for deprescription in these patients, and specific prescribing and deprescribing guidelines are needed for that specific population. Expand
A critical Examination of the Effectiveness of Pharmacological Intervention for Challenging Behaviour in Individuals with Intellectual Disabilities
Challenging behaviour can frequently have a detrimental effect on the quality of life of persons with intellectual disabilities and those around them. Given the often recurrent nature of challengingExpand
Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults
TLDR
Patients with two or more prior treatment failures are considered to have treatment-resistant depression (TRD); these TRD patients represent a complex population with a disease that is difficult to manage. Expand
Systematic Reviews of the Health or Health care of People with Intellectual Disabilities: A Systematic Review to Identify Gaps in the Evidence Base.
TLDR
Systematic reviews published in English from 2008 to 2013 on the health or health care of people with intellectual disabilities are heavily weighted towards mental health, with little coverage of several areas important to the health and mortality of peopleWith intellectual disabilities. Expand
Prescription errors in older individuals with an intellectual disability: prevalence and risk factors in the Healthy Ageing and Intellectual Disability Study.
TLDR
Interventions targeted to high risk patients should be designed and implemented to improve pharmacotherapy in older individuals with an intellectual disability. Expand
...
1
2
...

References

SHOWING 1-10 OF 38 REFERENCES
The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities.
TLDR
Presently, there is RCT-based evidence for risperidone to be effective in both adults and children; however, this treatment carries a certain amount of risk associated with adverse effects. Expand
The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review.
TLDR
The current evidence lends some support for the use of lithium and some antiepileptic mood stabilizer medication for the management of behaviour problems in adults with ID, however, the findings have to be interpreted with caution. Expand
Clozapine treatment in a population of adults with mental retardation.
TLDR
The current investigation lends support to the conclusion that clozapine appears to be safe, efficacious, and well tolerated in individuals with mental retardation and comorbid psychiatric illness. Expand
The use of risperidone among individuals with mental retardation: clinically supported or not?
TLDR
The effectiveness of risperidone in targeting psychopathology and challenging behaviors for individuals with mental retardation is questionable at present. Expand
Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder.
  • R. Jou, B. Handen, A. Hardan
  • Psychology, Medicine
  • Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
  • 2004
TLDR
Psychostimulants might be effective and well-tolerated in the treatment of ADHD in adults with MR and MR, however, larger prospective open-label studies, and, eventually, double-blind placebo-controlled studies are needed to confirm these findings. Expand
Review of serotonergic agents and perseverative behavior in patients with developmental disabilities
Studies of blood serotonin concentrations in autism and mental retardation suggest a possible dysfunction of serotonin in substantial proportions of patients. Clomipramine (CMI) and the selectiveExpand
Antipsychotic medication for challenging behaviour in people with learning disability.
TLDR
There is limited data on this important issue and more research is urgently needed on whether antipsychotic medication helps or harms adults with learning disability and challenging behaviour. Expand
Electroconvulsive Therapy for Affective Disorders in Persons with Mental Retardation
  • R. Kessler
  • Psychology, Medicine
  • Psychiatric Quarterly
  • 2004
TLDR
Electroconvulsive therapy is both as effective and safe with mentally retarded persons as in the general population, and issues of diagnostic difficulty and pharmacologic prophylaxis are addressed. Expand
Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
The Birmingham Special Needs Register, a computerized database, was used to examine the disabilities of, and the use of psychoactive (psychotropic and antiepileptic) drugs among 1825 people over theExpand
The use of psychotropic medication in people with learning disability: Towards rational prescribing
TLDR
The rate of psychotropic drug use seems to have declined in the last decade among the community‐based population and the two main reasons for the use of these drugs are psychiatric illness and behaviour disorder. Expand
...
1
2
3
4
...